WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 70.80
-0.10 (-0.14%)
Aug 12, 2025, 1:30 PM CST
ANSYS Market Cap
WeLeader Biomedical has a market cap or net worth of 3.22 billion as of August 11, 2025. Its market cap has increased by 4.80% in one year.
Market Cap
3.22B
Enterprise Value
3.56B
Revenue
1.00B
Ranking
n/a
PE Ratio
17.91
Stock Price
$70.80
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.22B, a decrease of -6.00%. That is a compound annual growth rate of -3.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 3.22B | -0.58% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 57.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.81B |
| Center Laboratories | 27.03B |
| Pegavision | 24.80B |